Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;2(2):96-103.
doi: 10.4103/0975-3583.83035.

Inflammation and diabetic retinal microvascular complications

Affiliations

Inflammation and diabetic retinal microvascular complications

Wenbo Zhang et al. J Cardiovasc Dis Res. 2011 Apr.

Abstract

Diabetic retinopathy (DR) is one of the most common complications of diabetes and is a leading cause of blindness in people of the working age in Western countries. A major pathology of DR is microvascular complications such as non-perfused vessels, microaneurysms, dot/blot hemorrhages, cotton-wool spots, venous beading, vascular loops, vascular leakage and neovascularization. Multiple mechanisms are involved in these alternations. This review will focus on the role of inflammation in diabetic retinal microvascular complications and discuss the potential therapies by targeting inflammation.

Keywords: Diabetic retinopathy; inflammation; microvascular complications.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Cascade of events that contribute to the inflammatory response in diabetic retinopathy. Hyperglycemia induces formation of advanced glycation end products, generation of reactive oxygen species from multiple sources, mainly nicotinamide adenine dinucleotide phosphate oxidase and mitochondrial electron transport chain, and dysregulation of nitric oxide synthase (NOS) pathway. These changes activate NF-kB and, in turn, upregulation of cytokines, chemokines and iNOS. This leads to upregulation of adhesion molecules and subsequent leukocyte/endothelial interaction

References

    1. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(Suppl 1):S84–7. - PubMed
    1. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, 3rd, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143–56. - PubMed
    1. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115:1859–68. - PMC - PubMed
    1. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: A systematic review. Eye (Lond) 2004;18:963–83. - PubMed
    1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–36. - PubMed